Open access
Jul 2026
Low-dose docetaxel reprograms CAR T cells for enhanced solid tumor immunity
This approach demonstrates enhanced CAR T cell performance against solid tumor barriers in preclinical models, highlighting the potential of chemotherapy-immunotherapy synergies.
Song-Shan Zhu, Jun Yin, Xin Fu et al.
· Journal of experimental & cl... · 1 citation